Emergent BioSolutions Inc. EBS announced today that it has closed on
its acquisition of Bracco Diagnostics Inc.'s Healthcare Protective Products
Division. This acquisition, which includes the RSDL^® (decontamination lotion)
product that is cleared for marketing by the U.S. Food and Drug Administration
(FDA) for removal or neutralization of chemical warfare agents from the skin,
diversifies and broadens Emergent's biodefense franchise into the chemical
countermeasure market.
“As a result of this transaction closing, Emergent is focused on the
uninterrupted supply of RSDL product to customers and on the seamless
integration of the new Healthcare Protective Products Group (HPPG) into our
biodefense division,” said Adam Havey, EVP and president of Emergent's
biodefense division. “This news, which comes on the heels of other positive
developments in our biodefense division, including receiving BioThrax^®
(Anthrax Vaccine Adsorbed) market authorization in Germany as well as
reporting positive data from our pivotal study supporting licensure of a
post-exposure prophylaxis indication for BioThrax, reinforces Emergent's
leadership position in the biodefense arena.”
The Canadian Department of National Defence and the U.S. Department of the
Army have both played a central role in the development and licensing of RSDL,
which is also cleared for sale by Health Canada, the U.K. Medicines and
Healthcare Products Regulatory Agency, and Australia's Therapeutics Goods
Administration.
The closing on this acquisition contemplates that certain additional assets
will be transferred to the company by year end. The company will discuss the
impact of this acquisition to Emergent's anticipated revenue and net income
for full year 2013 during the company's 2Q 2013 financial results call
scheduled for August 5, 2013.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in